Chimera Investment Corp. Cash & Equivalents increased by 69.8% to $483.03M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 90.7%, from $253.35M to $483.03M. Over 5 years (FY 2020 to FY 2025), Cash & Equivalents shows relatively stable performance with a 1.1% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Higher levels indicate strong liquidity and financial flexibility; lower levels may signal potential cash flow issues.
This represents the most liquid assets held by the company, including cash on hand, demand deposits, and short-term inve...
A universal metric for assessing a company's immediate financial health.
cash_and_equivalents| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $346.95M | $328.46M | $385.74M | $165.73M | $158.46M | $86.23M | $264.60M | $232.39M | $200.94M | $138.59M | $221.68M | $168.96M | $162.30M | $97.33M | $84.00M | $253.35M | $250.22M | $491.48M | $284.47M | $483.03M |
| QoQ Change | — | -5.3% | +17.4% | -57.0% | -4.4% | -45.6% | +206.8% | -12.2% | -13.5% | -31.0% | +60.0% | -23.8% | -3.9% | -40.0% | -13.7% | +201.6% | -1.2% | +96.4% | -42.1% | +69.8% |
| YoY Change | — | — | — | — | -54.3% | -73.7% | -31.4% | +40.2% | +26.8% | +60.7% | -16.2% | -27.3% | -19.2% | -29.8% | -62.1% | +49.9% | +54.2% | +405.0% | +238.7% | +90.7% |